FORM 8-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

March 19, 2026

Period of Report

March 18, 2026

Accession Number

0001437749-26-009063

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →